Econic Biosciences
Pre-clinicalExtrachromosomal DNA (ecDNA) is a little-known but widespread driver of oncogenic DNA amplification, which contributes to cancer’s evolution in unprecedented ways. It is found across most cancer types and its presence is associated with poor clinical outcomes. Econic Biosciences is building on novel mechanistic insights to develop specific approaches to therapeutically target ecDNA with the goal of improving treatment for individuals with cancer.
Private Company
Total funding raised: $19.5M
About
Extrachromosomal DNA (ecDNA) is a little-known but widespread driver of oncogenic DNA amplification, which contributes to cancer’s evolution in unprecedented ways. It is found across most cancer types and its presence is associated with poor clinical outcomes. Econic Biosciences is building on novel mechanistic insights to develop specific approaches to therapeutically target ecDNA with the goal of improving treatment for individuals with cancer.